This drug approval followed the publication of the EMBARK trial, a randomized phase III trial of biochemically recurrent patients who had high-risk disease, defined by a PSA doubling time (PSADT) ≤9 ...

Adrian Wojnarowski has been diagnosed with prostate cancer, the longtime ESPN basketball reporter revealed in a new interview ...

The TNM staging approach, which stands for tumour, nodes, and metastasis, is the most widely used method for staging prostate ...

PSA <0.2 ng/mL: Treatment was suspended at week 37 and PSA was monitored with treatment reinitiated if PSA rose again PSA >0.2 ng/mL: Treatment was continued PSA progression (HR 0.07, 95% CI 0.03–0.14 ...

Australia: New research published in BJU International suggests that the PSA free-to-total ratio (FTR) can serve as an ...

He left ESPN to become the general manager for the men’s basketball program at his alma mater, St. Bonaventure.

Research by Cancer Center genetic epidemiologist Burcu Darst, PhD, and scientists from the Canary Prostate Active ...

PSA is a protein produced by cells of the prostate gland, too much of which ... Following the news, shares of Janux hit an all-time high of $71.25. Wall Street has been paying a lot of attention ...

Adrian Wojnarowski is opening up about his decision to walk away from ESPN, revealing a recent prostate cancer diagnosis ...

Mr Brown, the honorary patron of Male Uprising Guernsey, which aims to increase awareness of male cancers, urged men to ...

Janux Therapeutics reports updated clinical data for JANX007, highlighting significant efficacy, safety, and durability in ...